Efficacy of three treatment schedules in severe meconium aspiration syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 1, 2004, Pages 60-65

  Salvia Roiges M D ^a   Carbonell Estrany, X ^a,b   Figueras Aloy, J ^a   Rodriguez Miguelez J M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Bronchoalveolar lavage; Dexamethasone; Meconium aspiration syndrome; Newborn; Oxygenation index; Surfactant

Indexed keywords

BERACTANT; DEXAMETHASONE; LUNG SURFACTANT; NITRIC OXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG LAVAGE; MALE; MECONIUM ASPIRATION; NEWBORN; OXYGEN THERAPY; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SURVIVAL; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; BRONCHOALVEOLAR LAVAGE; DEXAMETHASONE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MECONIUM ASPIRATION SYNDROME; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL;

EID: 1642455948     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310006142     Document Type: Article

References (30)

1. Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 1998; 45: 511-29
2. Dargaville PA, South M, McDougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138: 113-5
3. Davey AM, Becker JD, Davis JM. Meconium aspiration syndrome: physiological and inflammatory changes in a newborn piglet model. Pediatr Pulmonol 1993; 16: 101-8
4. Kaapa P. Meconium aspiration syndrome: a role for phospholipase A2 in the pathogenesis? Acta Pædiatr 2001; 90: 365-7
5. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87: 101-7
6. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92: 135-9
7. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48-52
8. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 1998; 132: 40-7
9. Soll RF, Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev 2000; 2: CD002054
10. Ohama Y, Itakura Y, Koyama N, Eguchi H, Ogawa Y. Effect of surfactant lavage in a rabbit model of meconium aspiration syndrome. Act Paediatr Jpn 1994; 36: 236-8
11. Cochrane CG, Revak SD, Merritt TA, et al. Bronchoalveolar lavage with kL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 1998; 44: 705-15
12. Lam BC, Yeung CY. Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 1999; 103: 1014-8
13. Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109: 1081-7
14. Soukka H, Halkola L, Aho H, Rautanen M, Kero P, Kaapa P. Methylprednisolone attenuates the pulmonary hypertensive response in porcine meconium aspiration. Pediatr Res 1997; 42: 145-50
15. Khan AM, Shabarek FM, Kutchback JW, Lally KP. Effects of dexamethasone on meconium aspiration syndrome in newborn piglets. Pediatr Res 1999; 46: 179-83
16. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001; 138: 92-100
17. Herting E, Rauprich P, Stichtenoth G, Walter G, Johansson J, Robertson B. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 2001; 50: 44-9
18. Balaraman V, Sood SL, Finn KC, Hashiro G, Vyehara CF, Easa D. Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury. Am J Respir Crit Care Med 1996; 153: 1838-43
19. Van der Bleek J, Plotz FB, Van Overbeek FM, Heikemp A, Beekhuis H, Wildevuur RH, et al. Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr Res 1993; 34: 154-8
20. Paranka MS, Walsh WF, Stancombe BB. Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res 1992; 31: 625-8
21. Rubin BK, Tomkiewicz RP, Patrinos ME, Easa D. The surface and transport properties of meconium and reconstituted meconium solutions. Pediatr Res 1996; 40: 834-8
22. Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol 1995; 173: 1301-5
23. Kojima T, Hattori K, Fujiwara T, Sasai-Takedatsu M, Kobayashi Y. Meconium-induced lung injury mediated by activation of alveolar macrophages. Life Sci 1994; 54: 1559-62
24. Shabarek FM, Xue H, Lally KP. Human meconium stimulates murine alveolar macrophage procoagulant activity. Pediatr Res 1997; 41: 267A
25. Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome. Unresolved issues. Pediatr Clin N Am 1993; 40: 955-81
26. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998; 101: E7
27. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000; 83: F177-81
28. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shan Karan S, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight-infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344: 95-101
29. American Academy of Pediatrics, Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-8
30. Halliday HL, Ehrenkranz RA. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2002; 2: CD001146